FDA inspection
Actelion Pharmaceuticals US Inc.: FDA inspection ending Oct 28, 2024
FDA inspection 1252745 · Voluntary Action Indicated (VAI) · Titusville, NJ
Key facts
| Inspection ID | 1252745 |
|---|---|
| Firm | Actelion Pharmaceuticals US Inc. |
| FEI number | 3021902393 |
| Address | 1125 Trenton Harbourton Rd |
| City | Titusville |
| State | NJ |
| ZIP | 08560 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Oct 28, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data